BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/03/2018

FDA Announces Revised Draft Guidance for Generic Doxycycline Hyclate Oral Delayed-Release Tablets

The FDA is releasing a revised draft guidance for the pharmaceutical industry on generic doxycycline hyclate oral delayed-release tablets, outlining product-specific recommendations for bioequivalence studies to support abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →